IP Library Granted Patent US 9,194,921
Granted Patent B2
US 9,194,921 · App. 13/717,412 · Granted Nov 24, 2015

Biological detector and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,194,921
App. No.
13/717,412
Granted
Nov 24, 2015
Kind
B2
Abstract

A biological detector includes a conduit for receiving a fluid containing one or more magnetic nanoparticle-labeled, biological objects to be detected and one or more permanent magnets or electromagnet for establishing a low magnetic field in which the conduit is disposed. A microcoil is disposed proximate the conduit for energization at a frequency that permits detection by NMR spectroscopy of whether the one or more magnetically-labeled biological objects is/are present in the fluid.

Claims (14)

1. A method for detecting a particle/target analyte in a sample, the method comprising:

providing a device comprising a magnet configured to produce a magnetic field of less than or equal to 1.5 T, a vessel configured to hold a sample and being located with the magnetic field, and a radio frequency (RF) coil located proximate the magnetic field;

introducing magnetic particles comprising target-specific moieties to a sample comprising a target analyte and non-target species, wherein the sample and the magnetic particles are within the vessel; and

non-optically detecting at least one particle/target analyte complex in the sample in the vessel by activating the RF coil proximate the magnetic field to provide energy at a frequency sufficient for nuclear magnetic resonance detection of the at least one particle/target analyte complex in the vessel.

2. The method according to claim 1 , wherein the detecting step is performed in the presence of the non-target species in the sample.

3. The method according to claim 2 , wherein the nuclear magnetic resonance detection comprises detecting a signal due to a change in relaxation time.

4. The method according to claim 3 , wherein the relaxation rate changes in the presence of the particle/target analyte complexes.

5. The method of claims 4 , wherein said changes are selected from relaxation times T 1 , T 2 , T 2 *, or a combination thereof.

6. The method according to claim 1 , wherein the RF coil wraps around the vessel.

7. The method according to claim 1 , wherein the magnet is a permanent magnet.

8. The method according to claim 1 , wherein the target-specific moieties are antibodies.

9. The method according to claim 8 , wherein the biological sample is blood or urine.

10. The method according to claim 1 , wherein the sample is a biological sample.

11. The method according to claim 1 , wherein the magnetic particles are superparamagnetic particles.

Assignments (4)
CHANGE OF NAME Recorded Sep 26, 2018
From: SANDIA CORPORATION
To: NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
Reel/Frame 047154/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2015
From: ALAM, TODD M.
To: SANDIA CORPORATION
Reel/Frame 036264/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2013
From: SILLERUD, LAUREL
To: THE REGENTS OF THE UNIVERSITY OF NEW MEXICO
Reel/Frame 029888/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2013
From: REGENTS OF THE UNIVERSITY OF NEW MEXICO, THE
To: STC. UNM
Reel/Frame 029945/0657 →